These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 18063935)
1. Histone deacetylase inhibitor valproic acid inhibits proliferation and induces apoptosis in KM3 cells via downregulating VEGF receptor. Dong XF; Song Q; Li LZ; Zhao CL; Wang LQ Neuro Endocrinol Lett; 2007 Dec; 28(6):775-80. PubMed ID: 18063935 [TBL] [Abstract][Full Text] [Related]
2. The effects of the histone deacetylase inhibitor valproic acid on cell cycle, growth suppression and apoptosis in multiple myeloma. Kaiser M; Zavrski I; Sterz J; Jakob C; Fleissner C; Kloetzel PM; Sezer O; Heider U Haematologica; 2006 Feb; 91(2):248-51. PubMed ID: 16461312 [TBL] [Abstract][Full Text] [Related]
3. In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor. Neri P; Tagliaferri P; Di Martino MT; Calimeri T; Amodio N; Bulotta A; Ventura M; Eramo PO; Viscomi C; Arbitrio M; Rossi M; Caraglia M; Munshi NC; Anderson KC; Tassone P Br J Haematol; 2008 Nov; 143(4):520-31. PubMed ID: 18986388 [TBL] [Abstract][Full Text] [Related]
4. Chronic administration of valproic acid inhibits PC3 cell growth by suppressing tumor angiogenesis in vivo. Gao D; Xia Q; Lv J; Zhang H Int J Urol; 2007 Sep; 14(9):838-45. PubMed ID: 17760752 [TBL] [Abstract][Full Text] [Related]
5. Multiple Molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo. Shabbeer S; Kortenhorst MS; Kachhap S; Galloway N; Rodriguez R; Carducci MA Prostate; 2007 Jul; 67(10):1099-110. PubMed ID: 17477369 [TBL] [Abstract][Full Text] [Related]
6. Modulation of adhesion and growth of colon and pancreatic cancer cells by the histone deacetylase inhibitor valproic acid. Jones J; Bentas W; Blaheta RA; Makarevic J; Hudak L; Wedel S; Probst M; Jonas D; Juengel E Int J Mol Med; 2008 Sep; 22(3):293-9. PubMed ID: 18698487 [TBL] [Abstract][Full Text] [Related]
7. [Effects of sodium valproate on proliferation and apoptosis of human myelodysplastic syndromes cell line MUTZ-1]. Chen BA; Zhao HH; Gao C; Shao ZY; Xia GH; Dohner K Ai Zheng; 2007 Dec; 26(12):1323-9. PubMed ID: 18076794 [TBL] [Abstract][Full Text] [Related]
8. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response. Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742 [TBL] [Abstract][Full Text] [Related]
9. Curcumin, a potent anti-tumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation. Liu HL; Chen Y; Cui GH; Zhou JF Acta Pharmacol Sin; 2005 May; 26(5):603-9. PubMed ID: 15842781 [TBL] [Abstract][Full Text] [Related]
10. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors. Cho HH; Park HT; Kim YJ; Bae YC; Suh KT; Jung JS J Cell Biochem; 2005 Oct; 96(3):533-42. PubMed ID: 16088945 [TBL] [Abstract][Full Text] [Related]
11. The novel inhibitor of histone deacetylase resminostat (RAS2410) inhibits proliferation and induces apoptosis in multiple myeloma (MM) cells. Mandl-Weber S; Meinel FG; Jankowsky R; Oduncu F; Schmidmaier R; Baumann P Br J Haematol; 2010 May; 149(4):518-28. PubMed ID: 20201941 [TBL] [Abstract][Full Text] [Related]
12. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells. Fedier A; Dedes KJ; Imesch P; Von Bueren AO; Fink D Int J Oncol; 2007 Sep; 31(3):633-41. PubMed ID: 17671692 [TBL] [Abstract][Full Text] [Related]
13. [Effects of tributyrin on SHI-1 leukemia cells in vitro]. Yin H; Chen ZX; Cen JN; Duan WM; Wang W; Fu JX Zhonghua Xue Ye Xue Za Zhi; 2004 Nov; 25(11):662-5. PubMed ID: 15634570 [TBL] [Abstract][Full Text] [Related]
14. Valproic acid promotes neuronal differentiation by induction of proneural factors in association with H4 acetylation. Yu IT; Park JY; Kim SH; Lee JS; Kim YS; Son H Neuropharmacology; 2009 Feb; 56(2):473-80. PubMed ID: 19007798 [TBL] [Abstract][Full Text] [Related]
15. Valproic acid is a selective antiproliferative agent in estrogen-sensitive breast cancer cells. Fortunati N; Bertino S; Costantino L; Bosco O; Vercellinatto I; Catalano MG; Boccuzzi G Cancer Lett; 2008 Feb; 259(2):156-64. PubMed ID: 18006146 [TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor gamma agonists potentiate the cytotoxic effect of valproic acid in multiple myeloma cells. Aouali N; Palissot V; El-Khoury V; Moussay E; Janji B; Pierson S; Brons NH; Kellner L; Bosseler M; Van Moer K; Berchem G Br J Haematol; 2009 Dec; 147(5):662-71. PubMed ID: 19793255 [TBL] [Abstract][Full Text] [Related]
17. The novel histone deacetylase inhibitor BML-210 exerts growth inhibitory, proapoptotic and differentiation stimulating effects on the human leukemia cell lines. Savickiene J; Borutinskaite VV; Treigyte G; Magnusson KE; Navakauskiene R Eur J Pharmacol; 2006 Nov; 549(1-3):9-18. PubMed ID: 16978604 [TBL] [Abstract][Full Text] [Related]
18. [Inhibitory effect of VPA on multiple myeloma U266 cell proliferation and regulation of histone acetylation]. Zhu YF; Ye BG; Shen JZ; Lin CM; Lin FA; Shen SF; Xu CB Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):638-41. PubMed ID: 20561418 [TBL] [Abstract][Full Text] [Related]
19. A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells. Ahn MY; Jung JH; Na YJ; Kim HS Gynecol Oncol; 2008 Jan; 108(1):27-33. PubMed ID: 17920664 [TBL] [Abstract][Full Text] [Related]
20. Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons. Kanai H; Sawa A; Chen RW; Leeds P; Chuang DM Pharmacogenomics J; 2004; 4(5):336-44. PubMed ID: 15289798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]